Posted by Michael Wonder on 21 Feb 2019
Indivior launches generic version of its Suboxone opioid drug
20 February 2019 - British drugmaker Indivior said on Wednesday it had launched a copycat version of its blockbuster opioid addiction drug Suboxone in the United States, just one day after a court decision cleared the way for its rivals to market generic versions of it.
The U.S. Supreme Court ruling marked a victory for India-based generic drug maker Dr. Reddy’s Laboratories, which had earlier been blocked.
While launching generic versions of one’s own treatments is not uncommon for drugmakers, it is pretty rare. In 2016, U.S. drug maker Mylan floated the first generic version of its allergy auto-injector EpiPen after a backlash over the product’s price.
